ISO 14117:2019
p
ISO 14117:2019
73915

Status : Published

en
Format Language
std 1 216 PDF + ePub
std 2 216 Paper
  • CHF216
Convert Swiss francs (CHF) to your currency

Abstract

This document specifies test methodologies for the evaluation of the electromagnetic compatibility (EMC) of active implantable cardiovascular devices that provide one or more therapies for bradycardia, tachycardia and cardiac resynchronization in conjunction with transvenous lead systems.

NOTE This document was designed for pulse generators used with endocardial leads or epicardial leads. At the time of this edition, the authors recognized the emergence of technologies that do not use endocardial leads or epicardial leads for which adaptations of this part will be required. Such adaptations are left to the discretion of manufacturers incorporating these technologies.

It specifies performance limits of these devices, which are subject to interactions with EM emitters operating across the EM spectrum in the two following ranges:

— 0 Hz ≤ ? < 385 MHz;

— 385 MHz ≤ ? ≤ 3 000 MHz

This document also specifies requirements for the protection of these devices from EM fields encountered in a therapeutic environment and defines their required accompanying documentation, providing manufacturers of EM emitters with information about their expected level of immunity.

Read sample 

Preview this standard in our Online Browsing Platform (OBP)

General information

  •  : Published
     : 2019-09
    : International Standard published [60.60]
  •  : 2
     : 134
  • ISO/TC 150/SC 6
  • RSS updates

Sustainable Development Goals

This standard contributes to the following Sustainable Development Goal

Got a question?

Check out our FAQs

Customer care
+41 22 749 08 88

Opening hours:
Monday to Friday - 09:00-12:00, 14:00-17:00 (UTC+1)